Current Strategies in the Treatment of Multiple Myeloma, Lymphoma and Leukemia 2012

Key Topics

• Novel approaches in the treatment of relapsed multiple myeloma
• The role of risk stratification and upfront therapies in multiple myeloma
• Novel therapies in the management of Hodgkin lymphoma
• Strategies and controversies of maintenance therapy for multiple myeloma
• Treatment and management options for indolent lymphomas
• Management options for aggressive lymphomas
• Risk stratified therapy of chronic lymphocytic leukemia (CLL)
• Novel treatment options in the management of T-cell lymphomas
• Treatment options in the management of myelodysplastic syndrome (MDS)
• Identify updates in the management of chronic myelogenous leukemia (CML)
• The importance of supportive care in the management of hematological malignancies
• Practice guidelines and its impact on cost and reimbursement issues in the management of hematological malignancies

Who should Attend

Radiation oncologists, hematologists/oncologists, pharmacists, researchers, physician assistants, registered nurses, fellows in training interested in new developments for treatment of hematological malignancies and nurse practitioners.